The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood

Journal of Leukocyte Biology

Volumn 81, Issue 6, 2007, Pages 1404-1413

  Brekke, Ole Lars ^a,b   Christiansen, Dorte ^a   Fure, Hilde ^a   Fung, Michael ^c   Mollnes, Tom E ^a,d  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c Tanox Biosystems Inc   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Complement receptor 3; Endotoxin; Sepsis

Indexed keywords

ANTICOAGULANT AGENT; CD11B ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A RECEPTOR; LEPIRUDIN; THROMBIN INHIBITOR;

ARTICLE; BLOOD; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; ESCHERICHIA COLI; GRANULOCYTE; HUMAN; HUMAN TISSUE; MONOCYTE; NONHUMAN; NORMAL HUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; UPREGULATION;

ANTIGENS, CD11B; ANTIGENS, CD14; COMPLEMENT ACTIVATION; COMPLEMENT C2; COMPLEMENT C3; COMPLEMENT C5A; COMPLEMENT FACTOR D; ESCHERICHIA COLI; GRANULOCYTES; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE-1 ANTIGEN; MEMBRANE PROTEINS; MONOCYTES; PHAGOCYTOSIS; RECEPTORS, COMPLEMENT; RESPIRATORY BURST; UP-REGULATION;

ESCHERICHIA COLI;

EID: 34249681296     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0806538     Document Type: Article

References (46)

1. Martin, G. S., Mannino, D. M., Eaton, S., Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554.
2. Brandtzaeg, P., Mollnes, T. E., Kierulf, P. (1989) Complement activation and endotoxin levels in systemic meningococcal disease. J. Infect. Dis. 160, 58-65.
3. Guo, R. F., Ward, P. A. (2005) The role of complement activation in sepsis. Annu. Rev. Immunol. 23, 821-852.
4. Takakuwa, T., Endo, S., Nakae, H., Kikuchi, M., Baba, N., Inada, K., Yoshida, M. (1994) Blood cytokine and complement levels in patients with sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84, 291-300.
5. Schultz, D. R., Arnold, P. I. (1990) Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, α 1-acid glycoprotein, and fibrinogen. Semin. Arthritis Rheum. 20, 129-147.
6. Guo, R. F., Huber-Lang, M., Wang, X., Sarma, V., Padgaonkar, V. A., Craig, R. A., Riedemann, N. C., McClintock, S. D., Hlaing, T., Shi, M. M., Ward, P. A. (2000) Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J. Clin. Invest. 106, 1271-1280.
7. Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., Ward, P. A. (1999) Protective effects of C5a blockade in sepsis. Nat. Med. 5, 788-792.
8. Newman, S. L., Mikus, L. K. (1985) Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3. J. Exp. Med. 161, 1414-1431.
9. Van Dijk, W. C., Verbrugh, H. A., van der Tol, M. E., Peters, R., Verhoef, J. (1979) Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization. Infect. Immun. 25, 603-609.
10. Gasque, P. (2004) Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41, 1089-1098.
11. Mollnes, T. E., Brekke, O. L., Fung, M., Fure, H., Christiansen, D., Bergseth, G., Videm, V., Lappegard, K. T., Kohl, J., Lambris, J. D. (2002) Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100, 1869-1877.
12. Huber-Lang, M. S., Younkin, E. M., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Curnutte, J. T., Erickson, R., Ward, P. A. (2002) Complement-induced impairment of innate immunity during sepsis. J. Immunol. 169, 3223-3231.
13. Ward, P. A. (2004) The dark side of C5A in sepsis. Nat. Rev. Immunol. 4, 133-142.
14. Van Amersfoort, E. S., Van Berkel, T. J., Kuiper, J. (2003) Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin. Microbiol. Rev. 16, 379-414.
15. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., Mathison, J. C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.
16. Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., Ulevitch, R. J. (1990) Structure and function of lipopolysaccharide binding protein. Science 249, 1429-1431.
17. Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., Gusovsky, F. (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689-10692.
18. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., Akira, S. (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122.
19. Hoebe, K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S. O., Goode, J., Lin, P., Mann, N., Mudd, S., Crozat, K., Sovath, S., Han, J., Beutler, B. (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signaling. Nature 424, 743-748.
20. Leturcq, D. J., Moriarty, A. M., Talbott, G., Winn, R. K., Martin, T. R., Ulevitch, R. J. (1996) Antibodies against CD14 protect primates from endotoxin-induced shock. J. Clin. Invest. 98, 1533-1538.
21. Ebong, S. J., Goyert, S. M., Nemzek, J. A., Kim, J., Bolgos, G. L., Remick, D. G. (2001) Critical role of CD14 for production of proinflammatory cytokines and cytokine inhibitors during sepsis with failure to alter morbidity or mortality. Infect. Immun. 69, 2099-2106.
22. Flaherty, S. F., Golenbock, D. T., Milham, F. H., Ingalls, R. R. (1997) CD11/CD18 leukocyte integrins: new signaling receptors for bacterial endotoxin. J. Surg. Res. 73, 85-89.
23. Tanhehco, E. J., Kilgore, K. S., Liff, D. A., Murphy, K. L., Fung, M. S., Sun, W. N., Sun, C., Lucchesi, B. R. (1999) The anti-factor D antibody, mAb 166-32, inhibits the alternative pathway of the human complement system. Transplant. Proc. 31, 2168-2171.
24. Fung, M., Lu, M., Fure, H., Sun, W., Sun, C., Shi, N. Y., Dou, Y., Su, J., Swanson, X., Mollnes, T. E. (2003) Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage. Clin. Exp. Immunol. 133, 160-169.
25. Fure, H., Nielsen, E. W., Hack, C. E., Mollnes, T. E. (1997) A neoepitope-based enzyme immunoassay for quantification of C1- inhibitor in complex with C1r and C1s. Scand. J. Immunol. 46, 553-557.
26. Garred, P., Mollnes, T. E., Lea, T. (1988) Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3. Scand. J. Immunol. 27, 329-335.
27. Bergh, K., Iversen, O. J. (1989) Measurement of complement activation in rabbit plasma or serum using monoclonal antibodies against C5a. Scand. J. Immunol. 29, 333-341.
28. Mollnes, T. E., Lea, T., Frøland, S. S., Harboe, M. (1985) Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand. J. Immunol. 22, 197-202.
29. Gordon, D. L., Avery, V. M., Rice, J. L., McDonald, P. J. (1989) Surface phagocytosis of Staphylococcus epidermidis and Escherichia coli by human neutrophils: serum requirements for opsonization and chemiluminescence. FEMS Microbiol. Immunol. 1, 417-423.
30. Nishimura, H., Gogami, A., Miyagawa, Y., Nanbo, A., Murakami, Y., Baba, T., Nagasawa, S. (2001) Bactericidal/permeability-increasing protein promotes complement activation for neutrophil-mediated phagocytosis on bacterial surface. Immunology 103, 519-525.
31. Segal, A. W. (2005) How neutrophils kill microbes. Annu. Rev. Immunol. 23, 197-223.
32. Wright, S. D., Jong, M. T. (1986) Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 164, 1876-1888.
33. Zarewych, D. M., Kindzelskii, A. L., Todd III, R. F., Petty, H. R. (1996) LPS induces CD14 association with complement receptor type 3, which is reversed by neutrophil adhesion. J. Immunol. 156, 430-433.
34. Bjerre, A., Brusletto, B., Mollnes, T. E., Fritzsonn, E., Rosenqvist, E., Wedege, E., Namork, E., Kierulf, P., Brandtzaeg, P. (2002) Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant. J. Infect. Dis. 185, 220-228.
35. Turner, M. W., Grant, C., Seymour, N. D., Harvey, B., Levinsky, R. J. (1986) Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential. Immunology 58, 111-115.
36. Vaporciyan, A. A., Ward, P. A. (1993) Enhanced generation of O2- by human neutrophils via a complement iC3b/Mac-1 interaction. Biol. Signals 2, 126-135.
37. Gordon, D. L., Rice, J. L., McDonald, P. J. (1989) Regulation of human neutrophil type 3 complement receptor (iC3b receptor) expression during phagocytosis of Staphylococcus aureus and Escherichia coli. Immunology 67, 460-465.
38. Wright, S. D., Ramos, R. A., Hermanowski-Vosatka, A., Rockwell, P., Detmers, P. A. (1991) Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173, 1281-1286.
39. Duchow, J., Marchant, A., Crusiaux, A., Husson, C., Alonso-Vega, C., De Groote, D., Neve, P., Goldman, M. (1993) Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria. Infect. Immun. 61, 4280-4285.
40. Sprong, T., Brandtzaeg, P., Fung, M., Pharo, A. M., Hoiby, E. A., Michaelsen, T. E., Aase, A., van der Meer, J. W., van Deuren, M., Mollnes, T. E. (2003) Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. Blood 102, 3702-3710.
41. Marder, P., Sawyer, J. S., Froelich, L. L., Mann, L. L., Spaethe, S. M. (1995) Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4- (4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]-benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist. Biochem. Pharmacol. 49, 1683-1690.
42. Sprong, T., Moller, A. S., Bjerre, A., Wedege, E., Kierulf, P., van der Meer, J. W., Brandtzaeg, P., van Deuren, M., Mollnes, T. E. (2004) Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide. Infect. Immun. 72, 3344-3349.
43. Greenblatt, J., Boackle, R. J., Schwab, J. H. (1978) Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall. Infect. Immun. 19, 296-303.
44. Fredrikson, G. N., Truedsson, L., Sjoholm, A. G. (1993) New procedure for the detection of complement deficiency by ELISA - analysis of activation pathways and circumvention of rheumatoid factor influence. J. Immunol. Methods 166, 263-270.
45. Morin, M., Schindler, R., Wakabayashi, G., Daumy, G., Dinarello, C. A., Gelfand, J. A. (1991) Picogram concentrations of endotoxin stimulate synthesis of IL-1 β and TNF α by human peripheral blood mononuclear cells exposed to recombinant human C5a. Eur. Cytokine Netw. 2, 27-30.
46. Medvedev, A. E., Flo, T., Ingalls, R. R., Golenbock, D. T., Teti, G., Vogel, S. N., Espevik, T. (1998) Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-κ B activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J. Immunol. 160, 4535-4542.